Optimal combinations for detection of prostate cancer: Systematic sextant and laterally directed biopsies versus systematic sextant and color doppler-targeted biopsies

Urology

Volumn 63, Issue 2, 2004, Pages 301-305

  Kravchick, Sergey ^a   Cytron, Shmuel ^b   Peled, Ronit ^b   London, Daniel ^b   Sibi, Yosef ^b   Ben Dor, David ^b  

^a NONE   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; RATING SCALE; STANDARD; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

EID: 1242319246     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.09.034     Document Type: Article

References (26)

1. Hodge K.H., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound-guided transrectal core biopsies of the prostate. J Urol. 142:1989;71-74.
2. Eskew L.A., Bare R.L., McCullough D.L. Systematic 5 region prostate biopsy is superior to the sextant method diagnosing carcinoma of the prostate. J Urol. 157:1997;199-202.
3. Babaian R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 163:2000;152-157.
4. Ravery V., Goldblatt L., Royer B., et al. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol. 164:2000;393-396.
5. Naughton C.K., Miller D.C., Mager D.E., et al. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores impact on cancer detection . J Urol. 164:2000;388-392.
6. Newman J.S., Bree R.L., Rubin J.M. Prostate cancer diagnosis with color Doppler sonography with histologic correlation of each biopsy site . Radiology. 195:1995;86-90.
7. Bree RL: The role of color Doppler and staging biopsies in prostate cancer detection. Urology 49(3A suppl): 31-34, 1997.
8. Kravchick S., Cytron S., Peled R., et al. Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology. 61:2003;977-981.
9. Fleshner N.E., O'Sullivan M., Fair W.R. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol. 158:1997;505-508.
10. Levine M.A., Ittman M., Melamed J., et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 159:1998;471-475.
11. Djavan B., Remzi M., Schulman C.C., et al. Repeat prostate biopsy who, how and when? Eur Urol. 42:2002;93-103.
12. Stewart C.S., Leibovich B.C., Weaver A.L., et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 166:2001;86-92.
13. Gore J.L., Shariat S.F., Miles B.J., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 165:2001;1554-1559.
14. Plawker M.W., Fleisher J.M., Vapner E.M., et al. Current trends in prostate cancer diagnosis and staging among United States urologists. J Urol. 158:1997;1853-1858.
15. Chan T.Y., Chan D.Y., Stutzman K.E., et al. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol. 166:2001;2181-2184.
16. Aus G., Bergdahl S., Hugosson J., et al. Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50-66 years implications for sampling order . Eur Urol. 39:2001;655-660.
17. Rifkin M.D., Sudakoff G.S., Archibald A.A. Prostate technique, results and potential application of color Doppler US scanning . Radiology. 186:1993;509-513.
18. Louvar E., Littrup P.J., Goldstein A., et al. Correlation of color flow in the prostate with tissue microvascularity. Cancer. 83:1998;135-140.
19. Ragde H., Kenny G.M., Murphy G.P., et al. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate. 32:1997;279-283.
20. Frauscher F., Klauser A., Volgger H., et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy impact on prostate cancer detection . J Urol. 167:2002;1648-1652.
21. Cho J.Y., Kim S.H., Lee S.E. Peripheral hypoechoic lesions of prostate evaluation with color and power Doppler ultrasound . Eur Urol. 37:2000;443-448.
22. Epstein J.I., Potter S.R. The pathological interpretation and significance of prostate needle biopsy finding implications and current controversies . J Urol. 166:2001;402-410.
23. Penson D.F., Grossfeld G.D., Li Y.-P., et al. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the Cancer of the Prostate Strategic Urological Research endeavor. J Urol. 167:2002;1653-1657.
24. Egevad L., Norlen B.J., Norberg M. The value of multiple core biopsies for predicting the Gleason score of prostate cancer. BJU Int. 88:2001;716-721.
25. Halpern E.J., Frauscher F., Forsberg F., et al. High-frequency Doppler US of the prostate effect of patient position . Radiology. 222:2002;634-639.
26. Halpern E.J., Frauscher F., Strup S.E., et al. Prostate high-frequency Doppler US imaging for cancer detection . Radiology. 225:2002;71-77.